EUVIMEDEUVIMED entdecken
Crossref

Strategic management of innovation risk in the biopharmaceutical industry: a UK perspective

C.R. Chandrasekar, C.V. Helliar, A.A. Lonie, W.A. Nixon, D.M. Power

International Journal of Healthcare Technology and Management · 1999

DOI: 10.1504/ijhtm.1999.001052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Healthcare Technology and Management, 1999. Verfasst von C.R. Chandrasekar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chandrasekar, C., Helliar, C., Lonie, A., Nixon, W., & Power, D. (1999). Strategic management of innovation risk in the biopharmaceutical industry: a UK perspective. International Journal of Healthcare Technology and Management. https://doi.org/10.1504/ijhtm.1999.001052

Vancouver

Chandrasekar C, Helliar C, Lonie A, Nixon W, Power D. Strategic management of innovation risk in the biopharmaceutical industry: a UK perspective. International Journal of Healthcare Technology and Management. 1999. doi:10.1504/ijhtm.1999.001052

BibTeX
@article{Chandrasekar1999,
  author = {Chandrasekar, C.R. and Helliar, C.V. and Lonie, A.A. and Nixon, W.A. and Power, D.M.},
  title = {Strategic management of innovation risk in the biopharmaceutical industry: a UK perspective},
  journal = {International Journal of Healthcare Technology and Management},
  year = {1999},
  doi = {10.1504/ijhtm.1999.001052}
}
Kostenlos starten →